BCL2 and cancer: Idelalisib induced PUMA via the AKT/GSK-3β/NF-κB pathway, p53 upregulated modolator of apoptosis, belonging to BH3-only Bcl-2 family, which play a key role in apoptosis in cancer cells (59).